A modern heart transplant rejection surveillance protocol utilizing cell-free DNA: A single-center experience

A modern heart transplant rejection surveillance protocol utilizing cell-free DNA: A single-center experience

BACKGROUND: Endomyocardial biopsy (EMBx) is considered the gold standard for rejection monitoring after heart transplantation; however, it is invasive and histologic interpretation has limitations. Sensitive blood biomarkers, including donor-derived cell-free DNA (dd-cfDNA), have emerged to decrease...

Full description

Bibliographic Details
Main Authors: Ayman Saeyeldin, MD, Staci McKean, MSN, Johanna Van Zyl, PhD, Valerie Darst, MSN, Shelley Hall, MD
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:JHLT Open
Subjects:
rejection
heart transplant
Dd-cfDNA
GEP
HeartCare
Online Access:http://www.sciencedirect.com/science/article/pii/S2950133424000259

Internet

http://www.sciencedirect.com/science/article/pii/S2950133424000259

Similar Items